Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
esperion therapeutics股票正在上涨。股票可能是在昨天报告超出预期的Q3融资结果后继续走强。此外,HC Wainwright & Co. 重申了对该股票的买入评级。
Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
esperion therapeutics股份正在交易上涨。该股可能是基于昨天发布的超出预期的第三季度融资业绩继续走强。此外,HC Wainwright & Co.重申了对该股票的买入评级。